International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Mol Med Rep 14: [Related article:] 655-660, 2016; DOI: 10.3892/mmr.2016.5331
Following the publication of this article, after having re-examined our manuscript, an error was noted in the Acknowledgments section regarding the funding of our study.
The Acknowledgments section should have appeared as follows:
“This work was supported by grants from the Kanazawa Medical University (nos. C2014-3, C2015-1 and S2014-15), a grant from the Strategic Research Project (no. H2012-16 [S1201022]) from Kanazawa Medical University, Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI no. #25460376) and from the Sumitomo Science Foundation in Japan.
We apologize to our funders for this error, and regret any confusion this may have caused.